Baseline Sympathetic Nervous System Activity Predicts Dietary Weight Loss in Obese Metabolic Syndrome Subjects
Author Interview: Nora Straznicky PhD MPH
Senior Research Officer
Human Neurotransmitters Laboratory
Baker IDI Heart & Diabetes Institute
PO Box 6492, St Kilda Rd Central
Melbourne VIC 8008 Australia
Nervous System Activity May Predict Successful Weight Loss
Obesity is caused by a complex combination of lifestyle, environmental and biological factors. Changes in the global food system, which is producing more processed, calorie dense foods, increasingly time-poor lifestyles, and the advent of the computer age has led to an imbalance between food consumption and energy expenditure through physical exercise. Beyond these modifiable factors are others that we can’t control—namely, our biology, which is estimated to contribute at least 40% to our body weight and shape. Our biology includes genetic makeup, hormonal, metabolic, and nervous system factors, and these each play in important role not only in the development of obesity, but also the pursuit to lose weight.
Weight loss: How are nerves involved?
Individuals vary widely in their ability to lose weight during dieting—some shed pounds easily whilst others really struggle. A recent study conducted by researchers from Baker IDI Heart and Diabetes Institute has examined how a person’s nerve activity may influence dietary weight loss.
The sympathetic nervous system is widely distributed throughout the body and subconsciously regulates many important functions including how much energy we burn during sleep and rest, the energy we use to digest and utilize food (known as the ‘thermic effect of food’) and the breakdown of fat during fasting and weight loss. The present study examined the relationship between activity of the sympathetic nervous system and subsequent weight loss, in a group of 42 obese individuals on a 12-week low calorie diet intervention program.
Nerve activity was measured by the technique of microneurography, which involves the insertion of metal microelectrodes, similar to an acupuncture needle, into nerve fascicles (a bundle of nerve fibers) in the lower leg. Electrical activity, representing nervous impulses travelling from the brain to skeletal muscle, is manually counted and expressed as the number of bursts per minute, as illustrated below.

Figure: Microneurographic recordings of sympathetic nerve activity from the peroneal nerve in the lower leg. Top shows raw nerve signals and the bottom integrated nerve signals. Asterisks represent electrical firing from within a single nerve.
Key findings of the study were that successful weight losers (who lost an average of 9 kg after 12-weeks dieting) had higher resting nerve activity at the start of the program compared to weight loss resistant individuals (who lost an average of 3 kg). Moreover, successful weight losers demonstrated large increases in nerve activity following a carbohydrate test meal, whereas the responses were minimal in weight loss resistant subjects. The study findings, which were published in the February 2012 edition of the Journal of Clinical Endocrinology & Metabolism, highlight the importance of biological determinants in weight loss success and suggest that nerve activity contributes significantly to metabolic efficiency.
What are the implications of this study?
These findings provide two opportunities: (1) the potential to identify those people who will benefit most from lifestyle weight loss interventions and (2) the development of weight loss treatments which stimulate this specific nervous activity.
Whilst microneurography is a highly specialized technique, limited to the realms of research laboratories, there are other more accessible measures of nerve activity, which may be used on a population level. The main chemical released from sympathetic nerves is ‘noradrenaline’ and blood levels of this hormone in the fasting state and in response to food intake could be used as an index of sympathetic activity.
Over the past decades, much effort has focused on the development of anti-obesity drugs that enhance weight loss, and the sympathetic nervous system has been a logical target. The ideal drug in this regard would be one that selectively stimulates metabolic efficiency (resting metabolic rate, dissipation of calories after food intake and the breakdown of fat tissue) without unwanted side effects. Unfortunately, because of the widespread distribution of the sympathetic nervous system within the body, any drug that stimulates this nerve activity often has effects on multiple organs and body functions. Therefore unwanted side-effects of such drugs may include an increase in heart rate and blood pressure, insomnia, dry mouth and constipation, which limits their long-term use. Currently, several ongoing trials are testing the long-term effectiveness and safety of drug combinations, which include a component acting on the sympathetic nervous system.
What can I do if I fall in the weight loss resistant category?
The good news is that moderate-intensity exercise training has beneficial effects on the thermic effect of food. Therefore, regular brisk walking, swimming or bike-riding may help to facilitate greater weight loss. It is also important to emphasize that even modest weight loss, favorably influences the risk factors associated with obesity (cholesterol profile, blood pressure, blood sugar). The key to success is perseverance, setting realistic body weight goals and recognizing that lifestyle change requires long-term commitment, involving vigilance to both food intake and physical activity.
What recommendations do you have for future research as a result of your study?
It is important to find out why some people have blunted nerve activity response to food intake. The underlying mechanisms need to be fully explored. The role of hormones such as insulin and cortisol as well as genetic factors, merit further investigation.
Conflict of interest: None
Reference:
Baseline Sympathetic Nervous System Activity Predicts Dietary Weight Loss in Obese Metabolic Syndrome Subjects
Nora E. Straznicky, Nina Eikelis, Paul J. Nestel, John B. Dixon, Tye Dawood, Mariee T. Grima,Carolina I. Sari, Markus P. Schlaich, Murray D. Esler, Alan J. Tilbrook,
Gavin W. Lambert,and Elisabeth A. Lambert
JCEM jc.2011-2320; doi:10.1210/jc.2011-2320